Status | Study |
Recruiting |
Study Name: Scleroderma Registry & Repository at the Hospital for Special Surgery Condition: Scleroderma Date: 2012-08-01 |
Completed |
Study Name: Nilotinib in the Treatment of Systemic Sclerosis Condition: Systemic Sclerosis Date: 2010-07-01 Interventions: Drug: Nilotinib (Tasigna) Patients will be treated with Nilotinib 400 mg two times a day for 6 months. |
Completed |
Study Name: Angiogenic/Angiostatic Mediators in Patients With Systemic Sclerosis Condition: Systemic Sclerosis Date: 2008-04-25 |
Completed |
Study Name: Imatinib Mesylate (Gleevec) in the Treatment of Systemic Sclerosis Condition: Systemic Sclerosis Date: 2007-11-07 Interventions: Drug: Imatinib Mesylate In initial phase, patients will be treated with Gleevec 400 mg daily for 12 mont |
Completed |
Study Name: Imatinib in Systemic Sclerosis Condition: Scleroderma, Systemic Date: 2007-07-24 Interventions: Drug: Imatinib mesylate 100 mg orally daily increased by 100 mg/day every 2 weeks to maximum of 400 mg d |
Completed |
Study Name: Efficacy and Safety of Imatinib in Scleroderma Condition: Scleroderma, Localized Scleroderma, Syste Date: 2007-05-29 Interventions: Drug: imatinib mesylate 6 month treatment with 400mg/day (per os) |
Not yet recruiting |
Study Name: Platelet Gel in Systemic Sclerosis Condition: Scleroderma, Systemic Date: 2007-04-19 Interventions: Drug: Platelet Gel |
Terminated |
Study Name: Thalidomide for Decreasing Collagen Biosynthesis in People With Progressive Systemic Sclerosis Condition: Scleroderma, Systemic Date: 2007-01-03 Interventions: Drug: Thalidomide Thalidomide |
Completed |
Study Name: Efficacy and Safety Study of GB-0998 for Treatment of Systemic Sclerosis Condition: Scleroderma, Systemic Date: 2006-07-03 Interventions: Drug: High-dose intravenous immunoglobulin (Venoglobulin-IH) |
Completed |
Study Name: Pulmonary Involvement in Scleroderma: A Clinical Study of the Safety and Efficacy of Mycophenolate Mofetil in Scleroderma Patients With Lung Involvement Condition: Scleroderma, Systemic Date: 2006-06-02 Interventions: Drug: Mycophenolate mofetil |